Recent advances in the synthetic and medicinal perspective of quinolones: A review
In the modern scenario, the quinolone scaffold has emerged as a very potent motif
considering its clinical significance. Quinolones possess wide range of pharmacological …
considering its clinical significance. Quinolones possess wide range of pharmacological …
Quinolone: a versatile therapeutic compound class
The discovery of nalidixic acid is one pinnacle in medicinal chemistry, which opened a new
area of research that has led to the discovery of several life-saving antimicrobial agents …
area of research that has led to the discovery of several life-saving antimicrobial agents …
Antiplasmodial and antimalarial activities of quinolone derivatives: An overview
YL Fan, XW Cheng, JB Wu, M Liu, FZ Zhang… - European Journal of …, 2018 - Elsevier
Malaria remains one of the most deadly infectious diseases globally. Considering the
growing spread of resistance, development of new and effective antimalarials remains an …
growing spread of resistance, development of new and effective antimalarials remains an …
Preparation of protamine-hyaluronic acid coated core-shell nanoparticles for enhanced solubility, permeability, and oral bioavailability of decoquinate
W Wei, M Lu, W Xu, NE Polyakov, AV Dushkin… - International Journal of …, 2022 - Elsevier
Decoquinate (DQ) has low oral bioavailability owing to its poor water solubility. In this study,
a DQ solid dispersion (DQ-SD) was fabricated using mechanochemical technology to …
a DQ solid dispersion (DQ-SD) was fabricated using mechanochemical technology to …
Accessible and distinct decoquinate derivatives active against Mycobacterium tuberculosis and apicomplexan parasites
RM Beteck, R Seldon, D Coertzen… - Communications …, 2018 - nature.com
The quinolone decoquinate is coadministered with feed for treatment of parasites which
cause coccidiosis in poultry. However, from a drug-development perspective, the biological …
cause coccidiosis in poultry. However, from a drug-development perspective, the biological …
Artemisone and artemiside are potent panreactive antimalarial agents that also synergize redox imbalance in Plasmodium falciparum transmissible gametocyte …
D Coertzen, J Reader, M Van Der Watt… - Antimicrobial Agents …, 2018 - Am Soc Microbiol
The emergence of resistance toward artemisinin combination therapies (ACTs) by the
malaria parasite Plasmodium falciparum has the potential to severely compromise malaria …
malaria parasite Plasmodium falciparum has the potential to severely compromise malaria …
Topical Delivery of Artemisone, Clofazimine and Decoquinate Encapsulated in Vesicles and Their In vitro Efficacy Against Mycobacterium tuberculosis
Vesicles are widely investigated as carrier systems for active pharmaceutical ingredients
(APIs). For topical delivery, they are especially effective since they create a “depot-effect” …
(APIs). For topical delivery, they are especially effective since they create a “depot-effect” …
The evaluation of ADME and pharmacokinetic properties of decoquinate derivatives for the treatment of malaria
The emergence of Plasmodium falciparum (Pf) parasite strains tolerant of the artemisinin
component and resistant to the other drug component in artemisinin combination therapies …
component and resistant to the other drug component in artemisinin combination therapies …
Elucidating the antimycobacterial mechanism of action of decoquinate derivative RMB041 using metabolomics
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), still remains one of the
leading causes of death from a single infectious agent worldwide. The high prevalence of …
leading causes of death from a single infectious agent worldwide. The high prevalence of …
An in vitro ADME and in vivo Pharmacokinetic Study of Novel TB-Active Decoquinate Derivatives
Tuberculosis (TB) is currently the leading cause of mortality due to an infectious disease,
despite the existence of multiple effective first-line and second-line drugs. The current anti …
despite the existence of multiple effective first-line and second-line drugs. The current anti …